| Financial Year |
March 31 2023 |
| Monetary Funds |
88,994,601.58 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
44,417,444.38 |
| Accounts Receivable |
998,580,243.85 |
| Advances to Suppliers |
133,636,222.74 |
| Other Receivables |
59,087,391.63 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
375,004,075.02 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
28,438,118.26 |
| Other Current Assets |
36,042,357.00 |
| Total Current Assets |
1,787,479,095.49 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
13,844,970.12 |
| Long-term Equity Investment |
79,361,883.87 |
| Investment Properties |
143,068,238.54 |
| Fixed Assetes |
302,914,776.92 |
| Under-construction Projects |
359,505,921.37 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
43,704,009.72 |
| R&D expenses |
-- |
| Goodwill |
59,804,405.76 |
| Long-Term Deferred and Prepaid Expenses |
1,921,075.92 |
| Deferred Income Tax Assets |
22,898,518.14 |
| Other Non-Current Assets |
44,744,948.57 |
| Sub-Total of Non-Current Assets |
1,317,298,174.02 |
| Total Assets |
3,104,777,269.51 |
| Short-Term Loans |
34,973,034.66 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,774,625.00 |
| Accounts Payable |
733,722,998.51 |
| Accounts Received In Advance |
5,419,223.26 |
| Employee Compensation Payable |
12,343,404.21 |
| Taxes Payable |
163,694,109.55 |
| Interest Payable |
-- |
| Dividend Payable |
1,103,225.78 |
| Other payables |
45,346,581.31 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
20,037,627.36 |
| Other Current Liabilities |
50,617,400.42 |
| Sub-Total of Current Liabilities |
1,384,406,917.39 |
| Long-term Loans |
3,210,833.33 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
12,483,520.25 |
| Deferred Income Tax Liabilities |
19,514,145.85 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
54,865,176.59 |
| Total Liabilities |
1,439,272,093.98 |
| Paid-In Capital(Or Share Stock) |
1,435,273,808.00 |
| Capital Surplus |
3,307,149,695.62 |
| Surplus Reserve |
13,830,958.17 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-3,068,106,353.69 |
| Minority Stockholder's Interest |
-4,762,750.49 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,670,267,926.02 |
| Owner's Equity（Stockholder's Equity） |
1,665,505,175.53 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,104,777,269.51 |
